Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

The autocrine hypothesis proposes that a cell produces and secretes a hormone-like substance that can interact with specific membrane receptors on its surface to induce effects such as proliferation1. Thus, a cancer cell could act to stimulate its own growth. Bombesin and bombesin-like peptides (BLPs) such as gastrin-releasing pep-tide (GRP) cause various physiological responses in mammals2, including stimulation of proliferation of 3T3 mouse fibroblasts3 and normal human bronchial epithelial cells in vitro4 and induction of gastrin cell hyperplasia and increased pancreatic DNA content in vivo in rats5,6. Human small-cell lung cancer (SCLC) cell lines produce and secrete BLPs7–12 and can express a single class of high-affinity receptors for BLPs13. Exogenously added BLPs can also stimulate the clonal growth and DNA synthesis of SCLC in vitro14,15. These findings suggest that BLPs function as autocrine growth factors for this tumour. One way to test this hypothesis is to interrupt the function of the endogenously produced BLPs. Here, we demonstrate that a monoclonal antibody to bombesin binds to the C-terminal region of BLPs, blocks the binding of the hormone to cellular receptors and inhibits the clonal growth of SCLC in vitro and the growth of SCLC xenografts in vivo. These results demonstrate that BLPs can function as autocrine growth factors for human SCLC.

[1]  J. Minna,et al.  Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. , 1980, Cancer research.

[2]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[3]  M. Erisman,et al.  Human lung small-cell carcinoma contains bombesin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Lehy,et al.  Chronic administration of bombesin stimulates antral gastrin cell proliferation in the rat. , 1983, Gastroenterology.

[5]  J. Habener,et al.  Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Bepler,et al.  Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.

[7]  D. Bostwick,et al.  Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro. , 1985, The Journal of clinical investigation.

[8]  K. Rajewsky,et al.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. , 1979, Journal of immunology.

[9]  J. Rivier,et al.  Bombesin, bombesin analogues, and related peptides: effects on thermoregulation. , 1978, Biochemistry.

[10]  G Nilsson,et al.  Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. , 1979, Biochemical and biophysical research communications.

[11]  A. Schonbrunn,et al.  Characterization of bombesin receptors in a rat pituitary cell line. , 1983, The Journal of biological chemistry.

[12]  S. Bloom,et al.  Bombesin production by human small cell carcinoma of the lung , 1982, Regulatory Peptides.

[13]  J. Rivier,et al.  Bomebesin: specific binding to rat brain membranes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Rozengurt,et al.  Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. M. Weir,et al.  Handbook of experimental immunology , 1967 .

[16]  T. O'donohue,et al.  Bombesin-like peptides in small cell lung cancer: biochemical characterization and secretion from a cell line. , 1983, Life sciences.

[17]  S. Bloom,et al.  Bombesin, somatostatin and neurotensin-like immunoreactivity in bronchial carcinoma. , 1981, The Journal of clinical endocrinology and metabolism.

[18]  J. Willey,et al.  Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. , 1984, Experimental cell research.

[19]  T. Moody,et al.  Bombesin-like peptides and receptors in human tumor cell lines , 1983, Peptides.

[20]  J. Minna,et al.  Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Cleveland,et al.  Development of a rapid microELISA assay for screening hybridoma supernatants for murine monoclonal antibodies. , 1982, Journal of immunological methods.

[22]  T. Moody,et al.  Bombesin-like peptides in rat brain: quantitation and biochemical characterization. , 1979, Biochemical and biophysical research communications.

[23]  C. Pert,et al.  High levels of intracellular bombesin characterize human small-cell lung carcinoma. , 1981, Science.

[24]  J. Minna,et al.  High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. , 1985, Life sciences.

[25]  J. Minna,et al.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.